argenx Announces U.S. FDA Acceptance of Biologics License Application for Subcutaneous Efgartigimod in Generalized Myasthenia Gravis with Priority Review Read more about argenx Announces U.S. FDA Acceptance of Biologics License Application for Subcutaneous Efgartigimod in Generalized Myasthenia Gravis with Priority Review
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022 Read more about ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
Black Sea Property AS: Notice of extraordinary general meeting – potential loan agreement for EPO Bulgaria Read more about Black Sea Property AS: Notice of extraordinary general meeting – potential loan agreement for EPO Bulgaria
Inventiva announces a new Director of the Board of Directors Read more about Inventiva announces a new Director of the Board of Directors
Nordea Bank Abp: Repurchase of own shares on 21.11.2022 Read more about Nordea Bank Abp: Repurchase of own shares on 21.11.2022
Salmon Evolution ASA - Mandatory notification of trade Read more about Salmon Evolution ASA - Mandatory notification of trade
Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 21 November 2022 Read more about Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 21 November 2022
NorAm Drilling AS - Third Quarter 2022 Results Read more about NorAm Drilling AS - Third Quarter 2022 Results